COMPANY

SANDOZ CANADA INCORPORATED

SANDOZ CANADA INCORPORATED: marketing authorisation holder for Bacitracin, Calcitonin, Daptomycin, Octreotide, Semaglutide, Vancomycin, Vasopressin, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

BacitracinPOLYTOPIC (DIN 01942921), Cancelled Post Market Regulator Health Canada
BacitracinSANDOZ CORTIMYXIN (DIN 02242485), Cancelled Post Market Regulator Health Canada
CalcitoninSANDOZ-CALCITONIN NS (DIN 02261766), Cancelled Post Market Regulator Health Canada
DaptomycinDAPTOMYCIN FOR INJECTION (DIN 02490838), Marketed Regulator Health Canada
OctreotideOCTREOTIDE ACETATE INJECTION - 100MCG/ML (DIN 02263173), Cancelled Pre Market Regulator Health Canada
OctreotideOCTREOTIDE ACETATE INJECTION - 200MCG/ML (DIN 02263181), Cancelled Pre Market Regulator Health Canada
OctreotideOCTREOTIDE ACETATE INJECTION - 500MCG/ML (DIN 02263203), Cancelled Pre Market Regulator Health Canada
OctreotideOCTREOTIDE ACETATE INJECTION - 50MCG/ML (DIN 02263165), Cancelled Pre Market Regulator Health Canada
SemaglutideSANDOZ SEMAGLUTIDE (DIN 02571501), Approved Regulator Health Canada
SemaglutideSANDOZ SEMAGLUTIDE (DIN 02571528), Approved Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02394626), Marketed Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02394634), Marketed Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02394642), Marketed Regulator Health Canada
VancomycinVANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02394650), Cancelled Post Market Regulator Health Canada
VasopressinVASOPRESSIN INJECTION USP (DIN 02247938), Marketed Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.